Belpointe Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,869
| Closed | -$340K | – | 922 |
|
|
2024
Q4 | $340K | Sell |
12,869
-8
| -0.1% | -$211 | 0.02% | 615 |
|
|
2024
Q3 | $330K | Buy |
12,877
+3,409
| +36% | +$87.3K | 0.02% | 637 |
|
|
2024
Q2 | $222K | Buy |
9,468
+1,826
| +24% | +$42.9K | 0.02% | 688 |
|
|
2024
Q1 | $220K | Buy |
+7,642
| New | +$220K | 0.02% | 709 |
|
|
2023
Q2 | – | Sell |
-21,610
| Closed | -$650K | – | 749 |
|
|
2023
Q1 | $650K | Sell |
21,610
-33,623
| -61% | -$1.01M | 0.04% | 454 |
|
|
2022
Q4 | $1.56M | Buy |
55,233
+25,235
| +84% | +$712K | 0.09% | 221 |
|
|
2022
Q3 | $986K | Buy |
+29,998
| New | +$986K | 0.07% | 297 |
|
|
2022
Q2 | – | Sell |
-4,462
| Closed | -$206K | – | 1137 |
|
|
2022
Q1 | $206K | Sell |
4,462
-464
| -9% | -$21.4K | 0.01% | 894 |
|
|
2021
Q4 | $302K | Sell |
4,926
-234
| -5% | -$14.3K | 0.02% | 707 |
|
|
2021
Q3 | $385K | Sell |
5,160
-3,339
| -39% | -$249K | 0.03% | 594 |
|
|
2021
Q2 | $787K | Buy |
8,499
+3,722
| +78% | +$345K | 0.06% | 353 |
|
|
2021
Q1 | $424K | Sell |
4,777
-4,009
| -46% | -$356K | 0.04% | 483 |
|
|
2020
Q4 | $819K | Buy |
+8,786
| New | +$819K | 0.07% | 290 |
|